The COVID-19 pandemic has affected every aspect of cancer care, putting cancer patients at higher risk of poor outcomes. The “Every Day Counts – The impact of COVID-19 on patient access to oncology care in Europe” publication aims to provide a comprehensive overview of the significant impact of COVID-19 on cancer patients and their access […]

EPF published the results of its survey on the impact of the COVID-19 pandemic on patients and patient organisations. The aim of this survey was to gather more information on the lived experience and impact of the COVID-19 pandemic on patients with chronic conditions, their communities and on patients’ organisations.

Myeloma Patients Europe (MPE) has developed a Q&A on COVID-19 vaccination for myeloma patients to answer some of the most frequently asked questions about the approved COVID-19 vaccines in Europe. It is available in German, Armenian, Romanian, Spanish, Macedonian, French, Slovak, Hebrew and Lithuanian. Portuguese, Danish and Finnish coming soon.

An interactive e-Learning course for health professionals.

While in most cases COVID-19 symptoms pass quickly, some people are suffering long-term effects. Visit EURORDIS’s new webpage on Long COVID to learn more about this COVID-19 infection form, whose symptoms can last for over 12 weeks.

Videos and podcasts for health workers and the public to address common questions about COVID-19 vaccines.

Nathalie Moll, Director General of EFPIA on “How can we future-proof medicines regulation in the post-COVID world?”.

As the COVID-19 vaccination programme starts to be rolled out, many young women are hesitant to accept the vaccine, citing concerns about fertility. Meanwhile, those offered the vaccine during pregnancy must decide whether they will accept, even though pregnant people were excluded from the clinical trials. Data on accidental pregnancies that occurred during the trials […]